cytarabine
- Product NDC
- 67457-455
- 11-digit product format
- 674570455
- Labeler code
- 67457
- Product ID
- 67457-455_78e513d1-cf0b-4cba-943c-04e792f57b44
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cytarabine
- Dosage form
- INJECTION
- Route
- INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA200915
- Marketing category
- ANDA
- Marketing start
- 2011-12-14
- Marketing end
- 2022-10-31
- Substance
- CYTARABINE
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-455-52 | 67457045552 | 10 VIAL in 1 CARTON (67457-455-52) > 5 mL in 1 VIAL (67457-455-00) | 10 vial | 2011-12-14 | 0000-00-00 | No | No | Current |